Haiyang W. Zhang
No.639 Zhizaoju Road
Shanghai, 200011, China
Shanghai, 200011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Brain network alterations in autoimmune diseases: Current status and future prospects.
Journal: iScience
Published: July 26, 2026
Head-to-Head Comparison of an IGF-1R Inhibitor Versus Intravenous Glucocorticoid for Active Thyroid Eye Disease: Design of a Randomized Clinical Trial.
Journal: Ophthalmology and therapy
Published: April 01, 2026
Resting-State Brain Activity, Functional Connectivity, and Orbital Imaging Changes in Restrictive Myopathy Associated with Thyroid Eye Disease.
Journal: Eye and brain
Published: March 06, 2026
Self-amplifying RNA therapy encoding CNTF with disulfiram co-delivery promotes optic nerve repair through microglial pyroptosis inhibition and RGC axonal regeneration.
Journal: Journal of nanobiotechnology
Published: November 25, 2025
Transcriptomic and Neuroimaging Decoding of Brain-Immune Crosstalk in Thyroid Eye Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 19, 2025
High-Throughput Tear Proteomics Reveals Multi-Faceted Signatures of Thyroid Eye Disease.
Journal: Investigative ophthalmology & visual science
Published: November 06, 2025
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial.
Journal: JAMA ophthalmology
Published: October 09, 2025
RDINet: A novel dynamic mapping model integrating radiomics and deep learning for predicting treatment response in thyroid eye disease.
Journal: Digital health
Published: September 25, 2025
Last Updated: 09/26/2026